BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9180158)

  • 1. Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.
    Park IK; Kim BJ; Goh YJ; Lyu MA; Park CG; Hwang ES; Kook YH
    Int J Cancer; 1997 May; 71(5):867-73. PubMed ID: 9180158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.
    Lyu MA; Choi YK; Park BN; Kim BJ; Park IK; Hyun BH; Kook YH
    Int J Cancer; 1998 Jul; 77(2):257-63. PubMed ID: 9650562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
    Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M
    Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
    Ellerbroek SM; Hudson LG; Stack MS
    Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynold LM
    Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
    Quax PH; de Bart AC; Schalken JA; Verheijen JH
    Prostate; 1997 Aug; 32(3):196-204. PubMed ID: 9254899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R; Torà M; Díaz VM; Real FX
    Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase.
    Ossowski L
    Cancer Res; 1992 Dec; 52(24):6754-60. PubMed ID: 1333882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
    Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
    Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro.
    Tonn JC; Kerkau S; Hanke A; Bouterfa H; Mueller JG; Wagner S; Vince GH; Roosen K
    Int J Cancer; 1999 Mar; 80(5):764-72. PubMed ID: 10048980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices.
    Koolwijk P; Sidenius N; Peters E; Sier CF; Hanemaaijer R; Blasi F; van Hinsbergh VW
    Blood; 2001 May; 97(10):3123-31. PubMed ID: 11342439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
    Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynolds LM
    J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.
    Gladson CL; Pijuan-Thompson V; Olman MA; Gillespie GY; Yacoub IZ
    Am J Pathol; 1995 May; 146(5):1150-60. PubMed ID: 7747809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
    Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
    Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
    Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
    Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.
    Testa JE
    Cancer Res; 1992 Oct; 52(20):5597-603. PubMed ID: 1327511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
    Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.